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ABSTRACT
Here we report a PCR-based DNA engineering
technique for seamless assembly of recombinant
molecules from multiple components. We create
cloning vector and target molecules flanked with
compatible single-stranded (ss) extensions. The
vector contains a cassette with two inversely
oriented nicking endonuclease sites separated by
restriction endonuclease site(s). The spacer
sequences between the nicking and restriction
sites are tailored to create ss extensions of
custom sequence. The vector is then linearized by
digestion with nicking and restriction endonu-
cleases. To generate target molecules, a single
deoxyuridine (dU) residue is placed 6–10nt away
from the 50-end of each PCR primer. 50 of dU the
primer sequence is compatible either with an ss
extension on the vector or with the ss extension of
the next-in-line PCR product. After amplification,
the dU is excised from the PCR products with the
USER enzyme leaving PCR products flanked by 30 ss
extensions. When mixed together, the linearized
vector and PCR products directionally assemble
into a recombinant molecule through complemen-
tary ss extensions. By varying the design of the PCR
primers, the protocol is easily adapted to perform
one or more simultaneous DNA manipulations such
as directional cloning, site-specific mutagenesis,
sequence insertion or deletion and sequence
assembly.
INTRODUCTION
The cloning and engineering of genes are widely used
techniques to study DNA and protein function. The
majority of strategies to engineer genes by site-directed
mutagenesis are based on the in vitro extension of a
template DNA strand from a synthetic oligonucleotide
encoding the desired mutation(s) (1–6). The percentage
of mutant clones recovered using these methods of
site-directed mutagenesis can vary from 0.1 to 460%
depending on the eﬃciency of the parental (unmutated)
DNA elimination step. However, more intricate DNA
engineering tasks such as a domain swap between several
DNA targets or sequence assembly from multiple frag-
ments largely depend on DNA cleavage by restriction
endonucleases and rejoining by DNA ligase. Several
strategies for creating and joining two independent
DNAs without the use of restriction endonucleases have
been developed. One such strategy uses overlap extension
employing two PCR steps (7–10). Two intermediate PCR
fragments with overlapping end sequences are ﬁrst
ampliﬁed, then re-annealed across the overlapping
sequences, extended and subsequently ampliﬁed with a
ﬂanking primer set (7). Though the idea is attractive, the
success of overlap PCR depends on eﬃcient cross-
annealing of intermediate PCR products and eﬀective
removal of unused internal primers to direct the second
ampliﬁcation of the full-length product.
Another known approach for PCR product engineering
and cloning is ligase-free UDG cloning (11–13). The
method employs PCR ampliﬁcations of vector and insert
with overlapping PCR primers containing multiple dU
residues within the overlap region. Treatment of over-
lapping PCR products with Uracil DNA Glycosylase
(UDG, also known as UNG) generates multiple abasic
sites that promote strand separation due to destabilized
base pairing. The 30 single-stranded tails then cross-anneal
to form a recombinant product. This strategy has several
limitations that have prevented this method from becom-
ing widely used for gene engineering. First, multiple
deoxyuridines (dU) must be incorporated into the 50 end
of the primer (at least one-third of the 50 overlapping tails
should consist of dU residues in order to achieve eﬃcient
strand separation). In the coding sequences that have low
A/T content, it might be diﬃcult to select the overlapping
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backbone; it only removes the base from the sugar. The
assembled recombinant product is left with the protruding
single-stranded ﬂaps, which have to be removed in vivo by
the repair machinery of the bacterial host thus increasing
the possibility of DNA rearrangements in vivo,o rb yin
vitro methods requiring extra manipulations and usually
eﬀecting yields (15–17). Finally, compatible dU tails have
to be introduced on plasmid vectors by PCR increasing
the possibility of incorporating unwanted mutations into
the plasmid backbone.
Here we present an improved method based on ligase-
free UDG-mediated cloning, referred to as USER
TM
(Uracil-Speciﬁc Excision Reagent) friendly DNA
Engineering. The USER
TM
friendly DNA engineering
method allows for multiple changes of the target DNA
with a minimum of manipulations by the experimenter.
The vector’s insertion site is ﬂanked by ss extensions of
designed length and nucleotide composition, allowing for
ligase-free directional cloning of PCR products. The
PCR reactions must be performed with a polymerase
which can incorporate a deoxyadenine opposite a dU.
Either Taq DNA polymerase or the proofreading DNA
polymerase, PfuTurbo Cx Hotstart DNA polymerase
(Stratagene) can be used to perform PCR ampliﬁcation
with dU-containing primers. The USER
TM
enzyme
removes the dU residues to generate 30 ss extensions on
PCR-ampliﬁed DNA fragments. While the described
approach is simple, it provides several advantages: (a)
single-stranded extensions may be longer than those
produced by restriction endonuclease cleavage; (b)
single-stranded extensions are not self-complementary,
nor are they complementary to each other, so the vector
molecule termini do not re-anneal to form transformable
circular DNA; and (c) each single-stranded extension
carries a unique nucleotide sequence, thereby permitting
the directional assembly of multiple PCR products into
the vector.
MATERIALS AND METHODS
Sourceof bacterial strains, plasmidsand enzymes
Eschericia coli NEB5-a competent cells, plasmids
pUC193, pGPS2.1 and pNEBR-R1 are from New
England Biolabs (Ipswich, MA). Plasmid pBind-Gal4-
EcR-053 was a gift from Rheogene (Norristown, PA).
Eschericia coli ER2267 cells were made competent using
standard CaCl2 procedure. All enzymes used in this study
are products of New England Biolabs, except for
PfuTurbo Cx Hotstart DNA Polymerase which was
from Stratagene (La Jolla, CA). Oligonucleotides and
primers were synthesized by the DNA synthesis facility of
New England Biolabs and are listed in Table 1.
Table 1. Oligonucleotide sequences
Oligonucleotides for vector pNEB206A construction
a
50-taaGCTGAGGGAAAGTCTAGAGGATCCTCTAGATGTCTCCTCAGCgttt
50-aaacGCTGAGGAGACATCTAGAGGATCCTCTAGACTTTCCCTCAGCttaat
Oligonucleotides for USER enzyme activity assay
50-GATTTCATTTTTTATTUATAACTTTATATTG
b
50-CAATATAAAGTTATAAATAAAAAATGAAATC
PCR primers for Cat gene engineering and cloning
c
Left: GGAGACAUCGGATCCATACCTGTGACGGAAG-30
Right: GGGAAAGUGGATCCAGGCGTTTAAGGGCACC-30
P1: ATATGGGAUAGTGTTCACCCTTGTTACACC-30
P2: ATCCCATAUGACCAGCTCACCGTCTTTCATTGCCATAC-30
P3: AGGTTCAUGCTGCCGTTTGTGATGGCTTCCATGTCG-30
P4: ATGAACCUGAATCGCCAGCGGCATC-30
PCR primers for RheoActivator gene engineering and cloning
d
R47: GGGAAAGUAACATGGTGATGCGGTTTTGGCAGTAC
R48: ATGGCAGUTGTTACGACATTTTGGAAAG
R49: ACTGCCAUCGCCCGCCCCGTTGACGCA
R50: ACTGGAGCUTAAGTTCGAGACTGTTGTGTC
R51: AGCTCCAGUGACTCTCTTAAGGTAGCCT
R52: AGGTCCCAUGTTGGCACCGGTCCTAGGCTGTGGAGAGAAAGGCAAAGTGG
R53: ATGGGACCUAAAAAGAAGCGTAAAGTCGCC
R54: ATCCCCGUCCCCCAACATATCCAGATCGAAATCGTCTAGCGCGT
R55: ACGGGGAUTCCCCAGGGCCGGGATTTACCCCCCA
R56: ACAGGCAUCTCGAACTCCCCACCGTACTCGTCAATTCC
R57: ATGCCTGTGGACAGGATTCTGGAGGCAGAGCTTGCTGTGG
R58: AGGAAAAGUGTGGAATCCTCTTCGCCCACTCAACAAG
R59: ACTTTTCCUCCTTGCCTCTGGATGACCAGGTCATATTGCTGCGGGCAGGC
R60: GGAGACAUATCTCCAATAAGGCGAAAGAAAAAC
aSequence shown in uppercase deﬁnes cassette boundaries. Sequence shown in lowercase represent PacI and PmeI compatible ends that allow
re-creating PacI and PmeI sites in pNEB206A vector.
bOligonucleotide has ﬂuorescein label on 50 and 30 ends.
cThe 50 ends of primer sequences shown in boldface can be cleaved-oﬀ from the corresponding PCR product with the USER enzyme thus creating
PCR fragment ﬂanked with 30-single-stranded extensions.
dpNEB206A-compatible sequences in primers R47 and R60 are shown in boldface. The insertion sequence in primer R52 is shown in italic. The point
mismatches in the primers compared to the template sequence are underlined.
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To construct the pNEB206A vector, a double-stranded
cassette was designed to have PacI and PmeI compatible
ends (Table 1). The cassette was then subcloned into
pUC193 that was linearized with PacI and PmeI restric-
tion endonucleases. After insertion of the cassette, the
multiple cloning site of pNEB206A is still in frame with
the lacZa gene, allowing screening for recombinants using
a-complementation. To prepare linear pNEB206A, 10mg
of plasmid DNA was digested with 40units of XbaI in
100ml of NEBuﬀer 4 for 18h at 378C and then nicked with
20 units of Nt.BbvCI for 1h at 378C. The cleaved DNA
was puriﬁed by phenol–chloroform extraction and ethanol
precipitation, dissolved in 100ml of TE buﬀer (10mM
Tris-HCl, pH 8.0, 0.1mM EDTA) and stored at  208C.
The concentration of the linearized vector pNEB206A was
determined spectroscopically at A260 and was adjusted
to 50ng/ml.
USER enzyme activity
USER enzyme is a mixture of E. coli uracil DNA
glycosylase and endonuclease VIII (18,19). Together
these two enzymes create a nick in a 34-mer oligonucleo-
tide duplex containing a single dU paired with a
deoxyadenine. To establish the optimal ratio of the
enzymes in the mixture, various amounts (ng) of
EndoVIII were pre-mixed with 0.2 units of UDG
(New England Biolabs) and the resulting mixtures were
assayed for complete nicking of 10pmol of substrate in
15min at 378Ci na1 0ml reaction buﬀer (50mM Tris-HCl
pH 7.5, 10mM MgCl2, 10mM DTT, 1mM ATP, 20mg/ml
BSA). The reactions were quenched by the addition of
10ml of 95% formamide, 0.1% xylene cyanol, 0.1%
bromphenol blue, 10mM EDTA, pH 11, and the reaction
products were analyzed on a 15% TBE-Urea denaturing
gel (Invitrogen, Carlsbad, Ca).
PCR amplification
PCR ampliﬁcations were performed using either Taq
DNA polymerase or PfuTurbo Cx Hotstart DNA poly-
merase (PfuCx) following manufacturer’s recommenda-
tions. PfuCx is a genetically engineered derivative of Pfu
DNA polymerase carrying a point mutation V93Q that
abolishes PCR inhibition by dU (20,21). Each 50ml PCR
reaction contained 20ng of template DNA, 0.2mM
dNTPs, 0.2mM of each primer and 0.5ml of DNA
polymerase. The template was ampliﬁed for 25 cycles
using cycling protocols as follows. For Taq DNA poly-
merase: the initial denaturation is 5min at 948C;
denaturation for 30s at 948C, annealing for 1min at
558C, polymerization is from 20s to 1min at 728C; ﬁnal
polymerization is for 5min at 728C. For PfuCx DNA
polymerase: initial denaturation is 5min at 958C; dena-
turation for 30s at 958C, annealing for 1min at 558C,
polymerization is from 20s to 1min at 728C; ﬁnal poly-
merization is 5min, at 728C. The amount of each PCR
product in 5ml of PCR mixture was evaluated by agarose-
gel electrophoresis. The PCR product concentration
should be at least 0.02pmol/ml or higher for eﬃcient
PCR fragment assembly.
Assembly andtransformation
For chloramphenicol acetyltransferase (Cat) gene engi-
neering, four assembly reactions were performed using
PCR fragments that had been ampliﬁed with either Taq
DNA polymerase or PfuCx DNA polymerase. Each
assembly reaction (20ml) contained 1ml (50ng) of linear
pNEB206A vector and 1ml (1 unit) of USER enzyme. Five
microlitre aliquots of the completed PCR reactions
were added directly to the assembly reactions as
indicated: assembly reaction 1—PCR reaction Cat926;
assembly reaction 2—PCR reactions Cat142 and
Cat792; assembly reaction 3—PCR reactions Cat461 and
Cat474; assembly reaction 4—PCR reactions Cat142,
Cat327 and Cat474. The ﬁnal volume of each reaction
was adjusted to 20ml by adding the appropriate volume of
1X PfuCx polymerase reaction buﬀer. The assembly
reactions were incubated for 15min at 378C to cleave at
dU residues and for an additional 15min at room
temperature to allow annealing of the complementary
extensions. Fifty microlitres of the competent cells were
transformed with 5ml of each assembly reaction. E. coli
ER2267 strain was used for transformations with Taq
DNA polymerase-derived assembly reactions, whereas
E. coli NEB 5-a strain was used for PfuCx polymerase-
derived assembly reactions. Transformants were selected
by plating 50ml of transformation reaction (from 1ml of
total outgrowth volume) on 3 LB plates supplemented
with Amp (0.1mg/ml), IPTG (0.2mM) and X-gal
(0.04mg/ml). The white (recombinant) and blue (vector
background) colonies were counted after 18h incubation
at 378C. The percentage of recombinant colonies was
determined by dividing the number of white colonies by
the total number of transformants. Assembly eﬃciency
was determined by comparing the number of transfor-
mants recovered from each assembly reaction to the
number of transformants resulting from transformation of
50ng of uncut plasmid pNEB206A.
RESULTS
Generating plasmid vectors withunique single-stranded
extensions
Recently, a variety of site-speciﬁc nicking endonucleases
were derived by genetically engineering their correspond-
ing restriction endonucleases (22–24). These enzymes nick
only one strand in double-stranded DNA and the orien-
tation of the recognition sequence deﬁnes whether the
top or bottom strand is nicked. When two inversely
oriented nicking sites are placed within a short distance, a
double-strand break may be achieved due to the strand
dissociation across the spacer sequence. However, the
generated single-stranded extensions are complementary
to each other as they solely derive from the spacer
sequence. By incorporating one or more restriction endo-
nuclease sites into the spacer sequence it is possible to
divide it into two halves, each having a unique sequence,
so the single-stranded extensions generated after the
1994 Nucleic Acids Research, 2007, Vol. 35, No. 6cleavage with restriction and nicking endonucleases are
not complementary to each other. The spacer sequence
between two nicking sites may be easily customized. This
ﬂexibility is available by changing the order, orientation
and spacing of the nicking sites with respect to the
adjacent restriction site(s) in the cassette.
A double-stranded oligonucleotide cassette containing
two inversely oriented nicking endonuclease Nt.BbvCI
sites (24) separated by two XbaI restriction endonuclease
sites were synthesized by annealing two complementary
single-stranded oligonucleotides (Table 1). Within the
cassette, each XbaI site was separated from the adjacent
Nt.BbvCI site by unique, 5-nucleotide long spacer
sequence as shown in Figure 1A. This cassette was then
subcloned into a polylinker of pNEB193 vector to make a
derivative referred to as pNEB206A. pNEB206A plasmid
was double-digested with XbaI and Nt.BbvCI as described
in Materials and Methods yielding linearized vector
ﬂanked by unique 8-nucleotide long 30 ss extensions
(Figure 1B). The nicking reaction should be performed
exactly as described in Materials and Methods because
Nt.BbvCI possesses a residual double-strand cleavage
activity, which is observed when vector DNA is over-
digested. The linearized vector was tested for complete
digestion by a transformation assay. Transformation
results yielded 4.0 10
3 blue colonies per microgram of
the linearized vector compared to 5.0 10
6 blue colonies
per microgram of uncut vector, indicating that only 0.08%
of the vector remains uncut.
USER friendly DNA engineering method
An overview. A general overview of this technique is
presented in Figure 2. The target DNA is ampliﬁed as
two overlapping intermediate fragments in separate
ampliﬁcation reactions. Accordingly, two pairs of primers,
(P1þRight) and (P2þLeft) are required for the two
ampliﬁcation reactions. The overlapping primers, P1 and
P2, are selected at the location of nucleotide sequence
manipulation, so that the desired sequence changes can be
engineered into the primer sequences. The P1 and P2
primers prime opposite strands of the target DNA and
overlap each other by 6–10 nucleotides at their 50 ends.
Each overlapping primer contains one dU residue that
ﬂanks the overlap region on the 30 side. To provide vector-
compatible extensions on PCR-ampliﬁed fragments, the
Left and Right primers are designed with 8 additional
nucleotides at their 50 ends. These 8 nucleotides are
identical to single-stranded extensions on the linearized
vector pNEB206A (Figure 1B), except for a 30 deoxythy-
mine, which in the primer sequences is replaced by a dU
residue. Downstream of these 8 nucleotides, the primer
sequences are complementary to target DNA speciﬁc
sequences. The two ampliﬁcation reactions are then
performed with primer pairs (Left primerþP2) and
(P1þRight primer). In the PCR reaction, the polymerases
incorporate an adenine opposite the template-strand dU.
Next, the dU residues are excised from the ampliﬁed
fragments using USER enzyme in the assembly reaction as
described in the Methods section. After phosphodiester
bond breakage, the terminal 50 single-stranded oligonu-
cleotides dissociate, leaving the PCR fragments ﬂanked by
a3 0 single-stranded extension on each end. The linearized
vector pNEB206A and the USER-treated PCR fragments
directionally assemble into the desired recombinant
molecule, as the inside 30 single-stranded extensions of
PCR fragments are complementary to each other, while
the outside 30 single-stranded extensions of PCR frag-
ments are complementary to the single-stranded exten-
sions on the linearized vector (Figure 2). Because the
extensions are 6–10 bases in length, ligation is not
required. The assembly reaction is extremely eﬃcient
and guarantees high yield of desired recombinants, which
only depends on the competence of the cell host. The
construct is now ready for transformation of chemically
competent E. coli cells.
The proposed method is easily adapted to perform
diﬀerent DNA manipulations because the only variable is
the design of the PCR primers, whereas steps 1 to 4 are
identical for virtually any DNA manipulation (Figure 2).
For example, directional cloning of any PCR product into
pNEB206A, may be achieved by using the Left and Right
primers shown in Figure 2. Two choices of overlapping
primer P1 and P2 design, suitable for site-speciﬁc
mutagenesis are depicted in Figures 2 and 3A. To perform
sequence insertion, the design of overlapping primer
design should be adapted as shown in Figure 3B.
To perform sequence deletion or sequence assembly, the
design of overlapping primers should be adapted as shown
in Figure 3C or D, respectively.
Preparation of the USER enzyme specific for dU. dU
residues can be incorporated into DNA by chemically
synthesizing a primer containing dU and extending the dU
primer with the PCR reaction, thus creating a unique
target for uracil DNA glycosylase that speciﬁcally acts on
Figure 1. Schematic representation of the pNEB206A cloning vector.
(A) pNEB206A vector was constructed by ligating a synthetic double-
stranded cassette into the PacI and PmeI sites of pNEB193. Within the
cassette, XbaI and Nt.BbvCI recognition sequences are underlined;
cleavage sites are shown by arrows. (B) For USER friendly cloning,
pNEB206A is double-digested with XbaI and Nt.BbvCI as described in
the Materials and methods section to produce linearized vector ﬂanked
by 30 single-stranded extensions on both ends.
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dU base, creating an abasic (AP) site, it does not cleave
the phosphodiester backbone. To create a ‘dU-nicking’
tool, UDG reactions must be supplemented with an
additional enzymatic activity capable of cleaving phos-
phodiester bonds speciﬁcally at AP sites. The technique
detailed here, requires a ‘dU-nicking’ tool that leaves a
5-phosphate which is suitable for ligation in vivo.
Upon screening various AP lyases, we found E. coli
endonuclease VIII (EndoVIII DNA glycosylase/AP lyase)
possesses the most appropriate AP site cleavage
characteristics. To determine the optimal ratio of
enzymes, a series of UDG and EndoVIII enzyme mixes
were prepared. In the mixes, the concentration of
EndoVIII varied from 4 to 256ng, while the concentration
of UDG was kept constant at 0.2 activity units, which is
enough to release 12pmol of uracil per minute (New
England Biolabs). The resulting mixtures were assayed for
complete nicking of 10pmol ds oligonucleotide substrate
containing a single dU residue as described in Materials
and Methods. The results of the assay (Figure 4) show
that complete digestion of substrate occurs with the
Figure 2. Schematic description of the USER friendly DNA Engineering method. Lines with the arrowheads symbolize PCR primers. Boldface lines
within the P1 and P2 primers and PCR products symbolize complementary overlapping sequences. Black triangles refer to the point mismatches in
the primers and white triangles refer to the resulting mutations in the PCR products. dU is indicated by ‘U’. The speciﬁc sequences GGAGACAU in
the left primer and GGGAAAGU in the right primer are designed for their compatibility with the vector pNEB206A sequence.
1996 Nucleic Acids Research, 2007, Vol. 35, No. 6mixture that has 32ng of EndoVIII. This enzyme mix,
USER enzyme, removes the dU nucleotide in a double-
stranded DNA molecule, leaving a single nucleotide gap
bordered by 50 and 30 phosphates.
Assembly and directional cloning of PCR products into
pNEB206A. For method development, the chloramphe-
nicol acetyltransferase (Cat) gene of the pGPS2.1 plasmid
(New England Biolabs) was chosen as a target on which to
perform sequence manipulations. At position 248nt of the
Cat gene, the silent mutation G to C was introduced to
create an NdeI restriction site (sequence changes are
shown by asterisks in Figure 5A). At position 575nt, the
codon CAT was replaced by GCT to introduce a
His193Ala substitution, which creates the catalytically
inactive variant of chloramphenicol acetyltransferase (25).
PCR primers used for Cat gene engineering and cloning
are listed in Table 1. Primer locations and their directions
within the Cat gene are shown in Figure 5A. Six PCR
fragments from the Cat gene were ampliﬁed either with
Taq or PfuCx polymerases using PCR primers shown in
Figure 5B. Two sets of assembly reactions, a set for each
DNA polymerase derived PCR products, were set up
as described in Materials and Methods and shown in
Figure 5C. Assembly reactions were incubated for 15min
at 378C to cleave at dU residues and then incubated for an
additional 15min at room temperature to allow annealing
of the complementary extensions. Five microlitres of each
assembly reaction was used for transformation and blue-
white selection was applied to distinguish transformants
carrying empty vector, which should form blue colonies.
Since the template pGPS 2.1 does not replicate in ordinary
lab strains of E. coli (26,27) all white colonies recovered
from transformation were counted as recombinants.
The Cat gene assembly data is summarized in Table 2.
The percentage of recombinant colonies, which was
A Site-specific mutagenesis:
U
U
P1 primer
P2 primer
Left primer
Target DNA
Right primer
P2 Primer
U
P1 Primer
U
Target DNA
C Sequence deletion:
Left Primer
Right Primer
P2 Primer
U
Target DNA 1
P1 Primer  
U
Target DNA 2
D Sequence assembly:
Left Primer
Right Primer
B Sequence insertion:
P2 Primer U
P1 Primer U
Target DNA
Left Primer
Right Primer
Figure 3. PCR primer design for various DNA manipulations. Only the
primer design aspects of the indicated DNA manipulations are shown.
The indicated DNA manipulations are completed by performing steps
1–4 shown in Figure 2. Lines with the arrowheads symbolize priming
sequences in PCR primers. Boldface lines within primers symbolize
overlapping sequences. dU is indicated by ‘U’ and ﬂank the over-
lapping sequences on their 30 side. (A) Site-speciﬁc mutagenesis. The
desired sequence change, shown as a black triangle, is introduced
downstream of dU into either of the overlapping primers P1 or P2. An
alternative is shown in Figure 2 where sequence changes are introduced
into the overlap sequence of both primers. (B) Nucleotide sequence
insertion. Overlapping primers P1 and P2 precisely prime the template
adjacent to the insertion site. The desired non-priming sequences are
added to the 50 ends of both primers (shown as angled lines). The
overlapping sequence is created from the 50 terminal 6–10 nucleotides
of the insertion sequences (shown as the boldface angled lines), while
the rest of the insertion sequence (shown as a dotted angled line) may
be of any desired length. (C) Nucleotide sequence deletion. The
overlapping primers P1 and P2 prime distant locations precisely
adjacent to the targeted deletion region (shown as a dotted line). To
create the overlapping sequence, the 50 end of one primer (P2) is
supplemented by a non-priming sequence complementary to the 50 end
sequence of the other primer (P1). (D) Sequence assembly. The
overlapping primers, P1 and P2, prime diﬀerent DNA templates. A
complementary copy of the 50 terminal sequence of one primer (P1) is
added to the 50 terminus of the other primer (P2) to create the
overlapping sequence necessary for joining two independent DNAs.
EndoVIII (ng):
UDG (0.2 u):
256
−
256
+ 
128
+
64
+
32
+
16
+
123456789 1 0
S
P2
P1
−
−
−
+
8
+
4
+
Figure 4. USER enzyme activity assay. A 34-mer oligonucleotide
duplex (10pmol) containing a single dU paired with a deoxyadenine
(Table 1) was incubated with a series of EndoVIII and UDG enzyme
mixtures for 15min at 378Ci na1 0ml of T4 DNA ligase reaction buﬀer
(50mM Tris-HCl pH 7.5, 10mM MgCl2, 10mM DTT, 1mM ATP,
20mg/ml BSA). The reactions were quenched by the addition of 10mlo f
95% formamide, 0.1% xylene cyanol, 0.1% bromophenol blue, 10mM
EDTA, pH 11, and the reaction products were analyzedon a 15%
TBE-Urea denaturing gel. S, 34-nt oligonucleotide substrate. P1 and
P2, 15nt and 18nt cleavage products, respectively. Two product bands
of diﬀering size result from the fact that the uracil is not in the centre
of the substrate. Lane 1—no enzyme added. Lane 2—reaction contains
0.2 units of UDG. Lane 3—reaction contains 256ng of EndoVIII.
Lanes 4–10, reaction contains 0.2 units of UDG and the amount of
EndoVIII shown above the respective lanes.
Nucleic Acids Research, 2007, Vol. 35, No. 6 1997determined by dividing the number of white colonies
by the total number of transformants, was calculated
for each assembly reaction. As can be seen from the
presented data, the PfuCx-derived assembly reactions
have a slightly higher percentage of recombinants
compared to Taq. The lower percentage of recombinants
for Taq-derived assembly reactions may be explained
by the variability of the 30 ends of PCR products. Due to
the absence of 30 to 50 proofreading activity, Taq
polymerase tends to add an extra base on the ends of
PCR fragments. PCR fragments carrying extra bases
interfere with eﬃcient assembly. This is easily noticeable
when comparing three-fragment assembly reactions:
the percentage of Taq-derived recombinants is 84%
compared to 95% obtained from PfuCx-derived assembly
reactions.
Next, we compared the fraction of recombinants
recovered from the assembly of one, two or three PCR
fragments. To determine assembly eﬃciency, the number
of recombinants obtained from each assembly reaction
was divided by the number of transformants obtained
from transformation of 50ng of uncut pNEB206A
plasmid, which was set to 100% (Table 2). The fraction
of recombinants obtained from one-fragment assembly
was similar for both tested DNA polymerases falling in
the range of 10% of the total cell competency. When
compared to one-fragment assembly, the fraction of
recombinants obtained from two- and three-fragment
assemblies was approximately 2-fold (3.8–6.3%) and
4-fold (2.3–2.6%) lower, respectively.
To verify recombinant plasmids for the expected
sequence changes, as well as for the presence of errors
introduced by PCR, plasmid DNA was puriﬁed from 48
randomly selected white colonies (6 colonies from each
assembly reaction) and sequenced across the Cat gene.
Sequencing data showed that all constructs recovered
Primer P2
UGAAAGGG
Right primer
U
GU
Primer P1
GGAGACAU
Left primer
G ATATGGGAT
C TATACCCTA
*
CAT gene AGGTTCAT CAT
TCCAAGTA GTA
U GCT
Primer P3
* *
Primer P4
U
A
Assembly Reaction 1:  pNEB206A + Cat 926
Assembly Reaction 2:  pNEB206A  + Cat 142 + Cat 792
Assembly Reaction 3:  pNEB206A  + Cat 461 + Cat 474
Assembly Reaction 4:  pNEB206A  + Cat 142 + Cat 327 + Cat 474
C
W.t. Cat gene
Creates NdeI site
Hys193Ala substitution
Creates NdeI & Hys193Ala
B
Cat 926 GGAGACAU UGAAAGGG (Left + Right primers):
GGAGACAU GUATACCCTA (Left + P2 primers): Cat 142
Cat 792 ATATGGGAU UGAAAGGG (P1 + Right primers):
Cat 461 UCCAAGTA (Left + P4 primers): GGAGACAU
Cat 474 AGGTTCAUGCT UGAAAGGG (P3 + Right primers):
Cat 327 ATATGGGAU UCCAAGTA (P1 + P4 primers):
Figure 5. Outline of the chloramphenicol (Cat) gene mutagenesis and assembly experiment. (A) PCR primer design strategy. Lines with the
arrowheads symbolize priming sequences in the PCR primers. Left and Right cloning primers contain 50 extensions compatible with the single-
stranded extensions on the linearized pNEB206A vector. The overlapping primers P1/P2 and P3/P4 are selected in the vicinity of the targeted
mutations. Asterisks designate the point mismatches in the primers compared to the template sequence. Overlapping primers are complementary to
each other within the boxed sequences. The 30 dT of the boxed sequence in the primer sequences is replaced by dU. (B) Schematic representation of
six PCR products ampliﬁed using the indicated primers. Cycling conditions are described in Materials and Methods. The label, Cat926 etc. shows the
PCR fragment size in bp. The ends of the PCR products are ﬂanked by the compatible overlapping sequences with a single dU residue at the
junction. (C) Four assembly reactions were carried out using the indicated PCR fragments to assemble a full-length Cat gene carrying the indicated
phenotype into pNEB206A.
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introduced NdeI site, and in all constructs from assembly
reactions 3 and 4 the codon CAT was replaced by codon
GCT indicating that mutagenesis eﬃciency was 100%.
No sequence rearrangements were detected at the vector–
fragment or fragment–fragment junctions (in total 72
junctions in 48 constructs), indicating exceptionally high
precision of assembly reactions. However, Taq- and
PfuCx-polymerase-derived constructs diﬀer in the
number of PCR errors. While no PCR errors were
detected in PfuCx-polymerase-derived constructs, Taq
DNA polymerase introduced 13 PCR errors per 24
constructs, which equals to  0.6 errors per each kilobase.
As noted above, the pGPS2.1 template does not
replicate in ordinary E. coli strains (26,27), therefore the
template background was not an issue in experiments
detailed here. However, elimination of plasmid template
is crucial in applications where PCR fragments are
ampliﬁed from ordinary plasmids carrying the ampicil-
lin-resistant gene. We have tested diﬀerent template
elimination protocols, and the most eﬃcient and the
least labor-intensive protocol is treatment of PCR
products with DpnI, which cleaves methylated DNA
(i.e. template DNA), but does not cleave PCR products.
Since DpnI works in the majority of PCR buﬀers,
digestion may be performed directly in the PCR fragment
mix. No additional puriﬁcation step is required
after digestion, but before proceeding to the assembly
step, DpnI should be heat-inactivated by incubation at
808C for 20min to prevent digestion of the pNEB206A
vector.
Rheoactivator gene engineering. The pNEBR-R1 plasmid
(Receptor plasmid for RheoSwitch Mammalian
Inducible Expression System) expresses an engineered
nuclear receptor heterodimer consisting of two proteins,
RheoReceptor-1 (Choristoneura furniferana ecdysone
receptor, CfEcR) and RheoActivator (Hybrid Human/
LocusT retinoid X receptor) (33,34). The two proteins
constitute the holoreceptor and regulate transcription of
genes cloned into the expression vector, pNEBR-X1
(New England Biolabs). The RheoActivator gene in
pNEBR-R1 is expressed from the constitutive ubiquitin
UbC promoter. We employed the USER friendly DNA
engineering method to modify the nucleotide sequence of
RheoActivator gene. A single-format experiment was
designed to achieve multiple goals such as: (i) to position
the RheoActivator gene under the control of the CMV
(early cytomegalovirus) promoter; (ii) to delete NcoI, PvuI
and PstI restriction sites from the CMV promoter; (iii) to
delete ApaI, SmaI, EcoRI, BclI and two BamHI restric-
tion sites from the Rheoactivator gene and (iv) to insert
two new restriction sites (AvrII and AgeI) between the
CMV promoter and the Rheoactivator gene. To achieve
this, a directional assembly of seven intermediate PCR
fragments into pNEB206A vector was performed. The
30terminal portion (540bp) of the CMV promoter was
ampliﬁed as three intermediate fragments, 153bp, 184bp
and 218bp in length. The junction sites within the CMV
promoter sequence were chosen in the vicinity of the NcoI,
PvuI and PstI sites targeted for elimination so that the
desired sequence changes could be engineered into the
primer sequences. Similarly, the Rheoactivator gene
sequence was split into four intermediate fragments,
144bp, 142bp, 190bp and 470bp in length, in the vicinity
of ApaI, SmaI, EcoRIþBamHI and BamHIþBclI sites
targeted for elimination. Fourteen PCR primers carrying
the intended sequence changes were designed to generate
seven intermediate PCR fragments (Table 1). The 50 ends
of the ﬂanking primers (R47 and R60) were extended by
8-nucleotide sequences suitable for cloning into
pNEB206A vector. The six pairs of the overlapping
primers (R48 and R49, R50 and R51, R52 and R53,
R54 and R55, R56 and R57, R58 and R59) were designed
to generate 8–9-nucleotide long overlaps at the respective
junctions of the PCR fragments. All PCR primers
contained a single dU residue ﬂanking the 30 side of the
overlap sequence. Three overlapping fragments of the
CMV promoter were ampliﬁed from pBind-Gal4-cf-EcR
plasmid template using the PfuCx DNA Polymerase and
primer pairs R47þR48, R49þR50 and R51þR52. The
four overlapping RheoActivator gene fragments were
ampliﬁed from pNEBR-R1 plasmid template using
primer pairs R53þR54, R55þR56, R57þR58 and
R59þR60. Agarose gel electrophoresis of the PCR
Table 2. Transformation eﬃciency of assembled PCR fragments generated either by Taq DNA polymerase or PfuCx DNA polymerase
Number of PCR
fragments assembled
(fragment size in bp)
Number of white colonies (recombinants)
a
c.f.u./50ng vector
Percentage of recombinant colonies
b (%) Assembly eﬃciency
c (%)
Taq DNA
polymerase
PfuCx DNA
polymerase
Taq DNA
polymerase
PfuCx DNA
polymerase
Taq DNA
polymerase
PfuCx DNA
polymerase
One (926) 1.12 10
4 1.52 10
5 98 99 9.7 11.0
Two (142,792) 0.44 10
4 0.85 10
5 91 98 3.8 6.2
Two (461, 474) 0.73 10
4 0.86 10
5 96 98 6.3 6.2
Three (142, 327,474) 0.26 10
4 0.36 10
5 84 95 2.3 2.6
aBlue–white selection was performed to distinguish the recombinant colonies (white) from the colonies carrying vector background (blue).
bPercentage of recombinants was determined by dividing the number of white colonies by the total number of transformants.
cAssembly eﬃciency shows what fraction of transformants is recovered from each assembly reaction compared to the total cell competency. Cell
competency of ER2267competent cells used for transformation of Taq-generated PCR fragments was 1.15 10
5c.f.u. per 50ng of uncut vector
pNEB206A. Cell competency of NEB5-a competent cells used for transformation of PfuCx-generated PCR fragments was 1.38 10
6c.f.u. per 50ng
of uncut vector pNEB206A.
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fragments (Figure 6A). The proper assembly of the
intermediate fragments was veriﬁed by performing a
15-min control ligation of the USER-treated PCR
products. Ligation is necessary to avoid dissociation of
the assembled products during agarose gel electrophoresis.
Agarose gel pattern of a 10ml sample from the ligation
reaction is shown in Figure 6A, lane 9. As expected, a
variety of intermediate ligation products were formed,
with the largest product being 1500bp (indicated by white
arrow). This is the size of the intended CMV promoter
and Rheoactivator gene fusion, indicating a full-length
assembly product was formed during directional assembly
of seven intermediate USER-treated PCR fragments.
For assembly into the pNEB206A vector, 5ml aliquots
from each PCR reaction were combined and digested with
2ml (40 units) of DpnI restriction endonuclease for 1h at
378C to destroy template plasmids. After completion of
digestion, DpnI was inactivated by incubation for 20min
at 808C. The PCR fragment mix was supplemented with
2ml (100ng) of the linearized pNEB206A and 2ml (2 units)
of the USER enzyme. The assembly reaction was then
incubated for 15min at 378C and an additional 30min at
room temperature. Escherichia coli NEB5-a competent
cells were transformed with 5ml of assembly reaction as
described in the Materials and methods section. The
transformants were selected on ampicillin plates by
performing blue/white screening. In total, 28 white
(recombinant) and 98 blue (vector background) colonies
were recovered from a 100ml aliquot of transformation
reaction. Next, 10 individual white colonies were screened
by colony PCR using primers R51 and R56 that will only
amplify clones carrying a fusion of the CMV promoter
and the Rheoactivator gene. The expected 500-bp PCR
fragment was produced in 8 out of 10 clones, suggesting
these clones carry the properly merged chimeric fusion
(Figure 6B). The restriction digestion analysis of plasmid
DNA puriﬁed from six positive clones revealed an
expected 1500-bp size insert that corresponded to the
full-length fusion of the CMV promoter and
Rheoactivator gene (Figure 6C). To conﬁrm nucleotide
sequence, all six plasmids were sequenced across the insert.
Nucleotide sequence analysis showed that all clones
carried the full set of intended sequence changes,
indicating 100% mutagenesis eﬃciency. No sequence
divergence at the PCR fragment junctions was observed.
However, three out of six clones showed either PCR-based
or primer-based point mutations.
DISCUSSIONS
Two new techniques were employed to develop a new
approach to customize DNA sequences. The ﬁrst techni-
que uses a new group of nicking endonucleases, which
cleave only one strand of ds DNA in a site-speciﬁc manner
(22–24). This site-speciﬁc nicking is used to create
insertion sites in vectors with unique non-palindromic 30
ss extensions. Ideally, the vector backbone should not
have additional nicking sites besides those in the cassette.
Thus, to create pNEB206A vector we used the nicking
endonuclease Nt.BbvCI (24) which recognizes the seven
base pair sequence, CC#TGAGG, and which is not
present (or infrequently present) in the sequences of
commonly used cloning vectors. We have now determined
that a complete absence of additional nicking sites is not
essential as long as nicked sites on opposite strands are
separated by at least 100bp. Currently, a variety of site-
speciﬁc nicking endonucleases recognizing either six or
seven base pair sequences are commercially available from
New England Biolabs, therefore the design of single-
stranded extensions on the vectors may be custom
modiﬁed by replacing the nicking/restriction sites in the
cassette. Recently, a comprehensive set of the USER
compatible vectors has been constructed by other
researchers for constitutive expression in a variety of
host organisms (35).
The other technique employed to customize DNA
sequences is an improvement to a ‘ligase-free UDG
cloning’ method (11). DNA ampliﬁcation using primers
with a single dU placed near their 50 end followed by
incubation with the USER enzyme creates PCR fragments
with unique non-palindromic 30 ss extensions. This allows
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Figure 6. Rheoactivator gene engineering. (A) Electrophoretic analysis of the PCR products ampliﬁed using PfuCx DNA Polymerase. 5ml of each
PCR reaction corresponding either to the CMV promoter ampliﬁcation products (Lanes 1–3) or to the Rheoactivator gene ampliﬁcation products
(Lanes 4–7) were loaded on a 1% agarose gel. Lane 1—PCR with primers R47þR48 (product size 153bp). Lane 2—PCR with primers R49þR50
(product size 184bp). Lane 3—PCR with primers R51þR52 (product size 218bp). Lane 4—PCR with primers R53þR54 (product size 144bp).
Lane 5—PCR with primers R55þR56 (product size 142bp). Lane 6—PCR with primers R57þR58 (product size 190bp). Lane 7—PCR with
primers R59þR60 (product size 470bp). Lane 8—50mg of the linearized pNEB206A vector. Lane 9—control ligation of the USER-treated PCR
fragments shown in Lanes 1–7. White arrow indicates the 1500-bp ligation product that represents the full-length CMVpromoter and Rheoactivator
gene fusion. Lane M corresponds to the 2-log DNA ladder. (B) Clone screening by PCR ampliﬁcation directly from 10 white colonies with primers
R51 and R56 that will only amplify clones carrying a CMV promoter and Rheoactivator gene fusion. (C), Plasmid DNA from clones 1, 2, 4, 5, 7 and
8 were analyzed by restriction digestion with BbvCI restriction endonuclease.
2000 Nucleic Acids Research, 2007, Vol. 35, No. 6for accurate, multi-fragment assemblies among the multi-
ple PCR fragments, as well as insertion into the vector,
all in one step.
The concept and experiments presented here are
ﬂexible, in that, many diﬀerent nicking enzyme speciﬁcities
could be used. Furthermore, diﬀerent modiﬁed bases
along with their cognate ‘repair’ enzyme can be used to
create breaks near the 50 ends of ampliﬁed fragments.
Several E. coli DNA glycosylases/AP lyases are capable of
breaking phosphodiester bonds at the AP-sites (19,28,29).
For example, formamidopyrimidine-DNA glycosylase,
also known as FPG, can excise a variety of oxidized
purines (29), whereas either DNA endonucleasae III or
endonuclease VIII both can excise a variety of oxidized
pyrimidines (19,28). Due to the AP-lyase activity, which
can act independently of associated glycosylase activity,
these enzymes are also capable of breaking phosphodiester
bonds at AP sites, but Endo III breaks the ﬁrst
phosphodiester bond 30 to the AP site (28), whereas
FPG and EndoVIII are capable of breaking phosphodi-
ester bonds on both 30 and 50 sides of the AP site (19,29).
In general, the combination of DNA glycosylases in the
mixture depends on (i) the type of modiﬁed nucleotide to
be excised and (ii) the type of termini desired at the nick
location. For example, by combining the uracil DNA
glycosylase hSMUG1 (30) with EndoVIII we have created
a nicking tool, which is speciﬁc for hydroxymethyluracil
(data not shown). A combination of three enzymes, UDG,
EndoIV and EndoVIII, was used to nick at dU and
generate a 50 phosphate and 30 hydroxyl at DNA termini
(data not shown).
We created an eﬃcient and fast method for assembly of
desired DNA molecules from multiple PCR fragments,
referred to as the USER friendly DNA engineering
method. The most distinctive feature of the technique is
its universality, as it combines nucleotide sequence
manipulation, PCR fragment assembly and directional
cloning in a single experimental format. By modiﬁcations
in the primers, which, during DNA ampliﬁcation are
incorporated into the ends of the PCR products, virtually
any envisioned DNA manipulation may be performed at
any location of a target DNA. The junction of PCR
fragments across single-stranded extensions generated by
the USER enzyme is extremely precise. Since the assembly
reaction is ligase free, the extensions with mismatched
sequences do not yield stable recombinant molecules and
are lost during transformation. In addition, when proof-
reading polymerase PfuCx is used for DNA ampliﬁcation,
the PCR errors are rare. PfuCx DNA polymerase is a
genetically engineered derivative of Pfu polymerase (21).
No wild-type proofreading DNA polymerases, such as
Vent, Deep-Vent or Pfu, can yield PCR product from
primers carrying dU (14,20). Archaeal DNA polymerases
possess a uracil-binding pocket which blocks extension
past a uridine (20,21). In addition to PfuCx, the other
DNA polymerase compatible with the USER friendly
DNA engineering method is Taq DNA polymerase.
Despite the fact that Taq polymerase has a higher error
rate, we have successfully used it in numerous site-speciﬁc
mutagenesis and gene fusion experiments where a two or
three PCR fragment assembly was required.
To date, the highest number of PCR fragments suc-
cessfully assembled in one reaction was seven. It should be
pointed out that the eﬃciency of directional assembly of
PCR fragments to a great degree depends on the unique-
ness of nucleotide sequences at the junctions. However, in
some cases, the choices for junction sequence selection are
very limited due to unfavorable A/T content of the target
DNA. Thus, when more than ﬁve PCR fragments are
assembled in the same reaction, there is a greater
possibility that junctions will have similar sequences and
the fragments may tend to assemble incorrectly, which
signiﬁcantly reduces the number of recombinants. For
example, in one of our experiments the goal was to delete
seven restriction sites from the LexA gene, thus a six-
fragment assembly was performed to introduce seven
silent mutations simultaneously. Initially, the percentage
of recombinants was very poor (14%), but by shifting the
position of one faulty junction we were able to eliminate
the mis-annealing of two intermediate fragments and the
yield of recombinants was increased to 60%.
In addition to altering the sequence of a target DNA,
the USER enzyme could be used in conjunction with
PfuCx DNA polymerase to amplify the cloning vector and
in the same reaction add sequence junctions compatible
for assembly of targeted PCR fragments. This approach
was successfully employed to generate precise protein
fusions for rapid protein puriﬁcation using either the
IMPACT
TM (Intein Mediated Puriﬁcation with an
Aﬃnity Chitin-binding Tag) system or the pMAL
TM
Protein Fusion and Puriﬁcation system (31,32). In
conclusion, the rapidity, precision and eﬃcacy of the
USER friendly DNA engineering method outweigh the
higher costs of dU in PCR primers, as well as a limited
choice of DNA polymerases.
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